Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database
Jonas Willmann(Memorial Sloan Kettering Cancer Center), Nicolaus Andratschke(University Hospital of Zurich), Anna Embring(Karolinska University Hospital), Peter Hoskin(University of Manchester), Matthias Gückenberger(University Hospital of Zurich), Heidi S. Rønde(Aarhus University Hospital), Dorota Gabryś(National Institute of Oncology), Madalyne Day(University of Zurich), Mariangela Massaccesi(Agostino Gemelli University Polyclinic), Carsten Nieder(Nordland Hospital Trust), Andreas Rimner(University Medical Center Freiburg), Panagiotis Balermpas(University of Zurich), Ane Appelt(University of Leeds), Louise Murray(Leeds Teaching Hospitals NHS Trust), Eliana Vásquez Osorio(University of Manchester), Charles W. Mayo(University of Michigan), Marianne G. Guren(Oslo University Hospital)
Cited by 12
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646